Insight Holdings Group Sells Shares of Hinge Health
Insight Holdings Group sold 1,466,667 shares of Hinge Health for $121.49 million.
Key Points
- Insight Holdings Group sold 1,466,667 shares of Hinge Health, Inc. on June 29, 2026, for $121.49 million at an average price of $82.84 per share.
- Hinge Health has a market cap of approximately $6.11 billion and a forward P/E ratio of 23.46, with shares trading near $78.97 on Tuesday.
- Analysts from firms like Wells Fargo and Raymond James maintained 'buy' ratings, with price targets ranging from $70 to $90.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Insight Holdings Group sold 1,466,667 shares of Hinge Health, Inc. (NYSE:HNGE) on June 29, 2026. The transaction, which was planned, took place at an average price of $82.84 per share, amounting to a total value of approximately $121.49 million.
What Changed in LLC Insight Holdings Group's Hinge Health Position
On June 29, 2026, Insight Holdings Group executed a planned sale of 1,466,667 shares of Hinge Health at an average price of $82.84 per share. This transaction was part of a pre-arranged trading plan.
Other Institutional Activity in Hinge Health
In other institutional activity, Deer Management Co. LLC opened a new position in Hinge Health with 2,633,707 shares valued at about $101.56 million. Bit Capital GmbH reduced its holdings by 1,006,304 shares, ending with 2,309,797 shares worth approximately $89.07 million, marking a 30.3% decrease. RTW Investments, LP significantly increased its stake by 1,576,500 shares, resulting in a 446% increase to 1,930,000 shares valued at $74.42 million. Fuller & Thaler Asset Management, Inc. also opened a new position with 1,655,198 shares valued at about $63.82 million.
Hinge Health, Inc. Stock Down 6.7%
As of Tuesday, shares of Hinge Health, Inc. (NYSE:HNGE) were trading around $78.97. The company boasts a market capitalization of about $6.11 billion and a forward P/E ratio of 23.46. Hinge Health's stock has a 52-week range between $30.08 and $79.26. The 50-day moving average is $56.38, and the 200-day moving average is $48.25. The company maintains a current ratio of 1.30 and a quick ratio of 1.04, with a debt-to-equity ratio of 2.24.
$HNGE stock price
Daily closing prices, year to date. Not investment advice.
Recent Earnings
Hinge Health reported revenue of $646.34 million, reflecting a growth rate of 47.2%. However, the company recorded a net margin of -78.95% and a return on equity of -136.00%. The next earnings report is scheduled for August 4, 2026.
Insider Buying and Selling at Hinge Health, Inc.
On June 29, 2026, Insight Holdings Group executed a planned sale of 1,466,667 shares at an average price of $82.84. Additionally, on June 25 and 24, Insight Holdings Group was involved in multiple transactions, including planned sales of 530,982 shares at $71.83 and 533,228 shares at $71.29.
Analysts Set New Price Targets
On June 24, 2026, Wells Fargo maintained its 'buy' rating for Hinge Health with a price target of $90. Other analysts like Raymond James and Canaccord Genuity also upheld 'buy' ratings with price targets of $80 and $76, respectively. The consensus among 15 analysts suggests a 'buy' recommendation with an average price target of $82.07.
About Hinge Health, Inc.
Hinge Health, Inc. is a healthcare company headquartered in San Francisco, California. Founded in 2012, it specializes in musculoskeletal care using technology, including AI-powered motion tracking and electrical nerve stimulation devices. The company primarily serves self-insured employers, focusing on acute injuries, chronic pain, and post-surgical rehabilitation. Led by CEO Daniel A. Perez, Hinge Health employs approximately 1,437 people.
Bottom Line
Insight Holdings Group's recent sale of Hinge Health shares highlights its ongoing investment strategy. Investors keep an eye on these transactions to gauge institutional confidence. As always, remember that 13F filings and insider trades are historical and may not reflect current positions.
Get Hinge Health, Inc. alerts
New 13F filings, insider trades, and analyst moves on $HNGE, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.